Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| REGN | Regeneron Pharmaceuticals, Inc. | -0.02% | 735.02 | 2.6% | $779.43m | |
| MRNA | Moderna, Inc. | 3.36% | 125.05 | 0.0% | $634.55m | |
| AMGN | Amgen, Inc. | 1.03% | 232.81 | 1.4% | $630.15m | |
| BIIB | Biogen, Inc. | 1.10% | 267.21 | 1.8% | $593.78m | |
| GILD | Gilead Sciences, Inc. | 3.55% | 64.53 | 1.0% | $549.45m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 0.86% | 299.98 | 1.9% | $430.51m | |
| ILMN | Illumina, Inc. | 7.54% | 201.36 | 3.2% | $378.78m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | 4.59% | 4.33 | 0.7% | $302.68m | |
| SAVA | Cassava Sciences, Inc. | 2.22% | 42.42 | 0.0% | $201.45m | |
| BNTX | BioNTech SE | 1.54% | 138.79 | 0.0% | $117.05m | |
| NVAX | Novavax, Inc. | 4.44% | 19.43 | 75.6% | $89.55m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 0.50% | 87.14 | 4.2% | $85.64m | |
| PRTA | Prothena Corp. Plc | 1.53% | 62.77 | 13.8% | $85.29m | |
| NRBO | NeuroBo Pharmaceuticals, Inc. | 1.06% | 13.40 | 0.0% | $81.11m | |
| TECH | Bio-Techne Corp. | 2.78% | 301.21 | 4.5% | $81.07m |
Company Profile
Viracta Therapeutics, Inc. a clinical-stage, biomarker-directed precision oncology company focused on new medicines for the treatment of virus-associated malignancies. It develops antiviral agent valganciclovir as an oral combination therapy which is in a Phase 2 clinical trial for EBV-positive lymphomas. The company was founded on February 10, 1998 and is headquartered in Cardiff, CA.